Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Apollo continues to invest in genomics technology and research for better patient care
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
